OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate

The OpenSAFELY Collaborative ., Brown A., Fisher L., Curtis H., Wiedemann M., Hulme W., Hopcroft LEM., Cunningham C., Speed V., Costello R., Galloway J., Russell M., Bechman K., Kurt Z., Croker R., Wood C., Walker A., Schaffer A., Bacon SCJ., Mehrkar A., Hickman G., Bates C., Cockburn J., Parry J., Hester F., Harper S., Goldacre B., MacKenna B.

DOI

10.1101/2023.06.06.23290826

Type

Preprint

Publication Date

2023-01-01T00:00:00+00:00

Keywords

The OpenSAFELY Collaborative

Permalink More information Close